Patents by Inventor Dieter Bromme

Dieter Bromme has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7799326
    Abstract: Methods and compositions for the amelioration of symptoms mediated by the collagenolytic activity of cathepsin K complex are provided. Methods of specifically modulating the collagenolytic activity of cathepsin K without substantial interference in other biologically-relevant activities of cathepsin K are further provided.
    Type: Grant
    Filed: September 24, 2002
    Date of Patent: September 21, 2010
    Assignee: Mount Sinai School of Medicine
    Inventor: Dieter Bromme
  • Publication number: 20040241157
    Abstract: The present invention relates to methods and compositions for the amelioration of symptoms mediated by the collagenolytic activity of cathepsin K complex. The invention provides methods of specifically modulating the collagenolytic activity of cathepsin K without substantial interference in other biologically-relevant activities of cathepsin K.
    Type: Application
    Filed: July 8, 2004
    Publication date: December 2, 2004
    Inventor: Dieter Bromme
  • Publication number: 20030175937
    Abstract: The invention relates to cathepsin O2 proteins, nucleic acids, and antibodies.
    Type: Application
    Filed: December 13, 2002
    Publication date: September 18, 2003
    Applicant: Khepri Pharmaceuticals, Inc.
    Inventors: Dieter Bromme, Kathleen Okamoto
  • Patent number: 6544767
    Abstract: The invention relates to cathepsin O2 proteins, nucleic acids, and antibodies.
    Type: Grant
    Filed: October 2, 1995
    Date of Patent: April 8, 2003
    Assignee: Axys Pharmaceuticals, Inc.
    Inventors: Dieter Brömme, Kathleen Okamoto
  • Patent number: 5736357
    Abstract: The invention relates to cathepsin O proteins, nucleic acids, and antibodies.
    Type: Grant
    Filed: October 27, 1994
    Date of Patent: April 7, 1998
    Assignee: Arris Pharmaceutical
    Inventors: Dieter Bromme, Kathleen Okamoto